A Rational Pipeline for Development of Novel Anti-TB Drug Regimens

Principal Investigator: David Russell

Department of Microbiology and Immunology

Email: dgr8@cornell.edu

Sponsor: The Mueller Health Foundation

Title: A Rational Pipeline for Development of Novel Anti-TB Drug Regimens

Project Amount: $1,992,356

Project Period: September 2021 to August 2025